Search Results
Jan 08, 2026, 10:30 ET VYLOY™ (zolbetuximab) Plus Chemotherapy Associated with Enhanced Survival Outcomes when Common Adverse Events are Effectively Managed, According to New Ad Hoc Analyses
(i) changes in general economic conditions and in laws and regulations, relating to pharmaceutical markets, (ii) currency exchange rate fluctuations, (iii) delays in new product launches, (iv) the inability of Astellas to market existing and new products effectively, (v) the inability of Astellas to continue
More news about: Astellas Pharma Inc.
Jan 08, 2026, 10:21 ET Jones Walker Elects 12 New Partners and Reelects Strong Board Leadership
Robert A. Mahtook, III is a member of the Corporate Practice Group and the Energy, Environmental & Natural Resources Industry Team in the Lafayette office. Robbie also
More news about: Jones Walker LLP
Jan 08, 2026, 09:00 ET Skye Bioscience, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before January 16, 2026 to Discuss Your Rights - SKYE
effective than defendants had led investors to believe; (ii) accordingly, nimacimab's clinical, regulatory, and commercial prospects were overstated; and (iii) as a result, defendants' public statements were materially false and misleading at all relevant times.DEADLINE: January 16, 2026 Shareholders
More news about: The Gross Law Firm
Jan 08, 2026, 09:00 ET SLM Corporation Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 17, 2026 to Discuss Your Rights - SLM
loss mitigation and/or loan modification programs, as well as the overall stability of the Company's private education loan delinquency rates; and (iii) as a result, defendants' public statements made a materially false and misleading impression regarding SLM's business, operations, and prospects at
More news about: The Gross Law Firm
Jan 08, 2026, 09:00 ET DeFi Technologies Sued for Securities Law Violations - Contact The Gross Law Firm Before January 30, 2026 to Discuss Your Rights - DEFT
treasury companies and the extent to which that competition would negatively impact its ability to execute its DeFi arbitrage strategy; (iii) as a result of the foregoing issues, the Company was unlikely to meet its previously issued revenue guidance for the fiscal year 2025; (iv) accordingly,
More news about: The Gross Law Firm
Jan 08, 2026, 09:00 ET Firefly Aerospace Inc. Class Action: The Gross Law Firm Reminds Firefly Aerospace Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 12, 2026 - FLY
for its Spacecraft Solutions offerings; (ii) Firefly had overstated the operational readiness and commercial viability of its Alpha rocket program; (iii) the foregoing, once revealed, would likely have a material negative impact on the Company; and (iv) as a result, the offering documents and defendants'
More news about: The Gross Law Firm
Jan 08, 2026, 08:59 ET Premiera modeli 116UXS i XR10 firmy Hisense na CES 2026 wprowadza RGB MiniLED w nową erę
rozwiązaniach IT. W rankingu firmy analitycznej Omdia firma Hisense zajmuje pozycję lidera w segmencie telewizorów 100-calowych i większych (lata 2023 - III kwartał 2025). Firma Hisense, będąca twórcą technologii RGB MiniLED, wprowadza dalsze innowacje w zakresie telewizorów RGB MiniLED nowej generacji. Jako
More news about: Hisense
Jan 08, 2026, 08:36 ET Sustained Therapeutics Reports Positive Phase 2 Results for Its Long-Acting Non-Opioid Medication for Chronic Pain
Plans to seek regulatory approval to commence a Phase III trial in the US and CanadaVANCOUVER, BC, Jan. 8, 2026 /PRNewswire/ --
More news about: Sustained Therapeutics
Jan 08, 2026, 08:15 ET Distinguished Neuroscience Expert Magali Haas, MD/PhD, Joins Psilera as Chief Medical Officer
marks an important milestone as we look to a critical growth year ahead."With a proven track record leading numerous positive Phase II & III global clinical trial programs, Dr. Haas will aid Psilera in developing PSIL-006 and other pipeline assets through FDA approval. Her tenure as Founder,
More news about: Psilera, Inc.
Jan 08, 2026, 06:45 ET CMC Reports First Quarter of Fiscal 2026 Results
allow: (i) comparison of our earnings to those of our competitors; (ii) a supplemental measure of our underlying business operational performance; and (iii) the assessment of period-to-period performance trends. Management uses non-GAAP financial measures to evaluate financial performance. We have not reconciled
More news about: Commercial Metals Company
Jan 08, 2026, 06:01 ET Ucommune Announces Extraordinary General Meeting
Ordinary Shares"), and (iii) 20,000 Series A Preferred Shares, par value US$0.024 per share (the "Series A Preferred Shares") to US$72,000,000 divided into 3,000,000,000 shares comprising (i) 2,994,000,000 Class A Ordinary Shares, (ii) 3,000,000 Class B Ordinary Shares, and (iii) 3,000,000 Series A Preferred
More news about: Ucommune International Ltd
Jan 08, 2026, 05:11 ET Ark Biopharmaceutical Receives China Marketing Authorization for Aizhida for the Treatment of ADHD
inconvenience, highlighting the need for additional therapeutic options.Robust Clinical Data Addresses Unmet Need: In a pivotal Phase III clinical trial in Chinese patients with ADHD, Aizhida met both the primary and key secondary endpoints. The study demonstrated statistically significant
More news about: Arkbio
Jan 08, 2026, 04:53 ET Ark Biopharmaceutical Receives China Marketing Authorization for Aizhida for the Treatment of ADHD
inconvenience, highlighting the need for additional therapeutic options.Robust Clinical Data Addresses Unmet Need: In a pivotal Phase III clinical trial in Chinese patients with ADHD, Aizhida met both the primary and key secondary endpoints. The study demonstrated statistically significant
More news about: Arkbio
Jan 08, 2026, 03:00 ET AbolerIS Pharma Announces First Patient Dosed in Part II of Phase 1 Study of ABO21009, a Novel Anti-CD45RC Antibody, for Rheumatoid Arthritis
dosing in healthy volunteers (part I), single ascending dosing in patients with RA (part II) and multiple ascending dosing in patients with RA (part III) to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of ABO21009. In part I, 24 patients were enrolled and received one of four
More news about: AbolerIS Pharma
Jan 08, 2026, 01:11 ET Hisense Pamerkan Ekosistem "Smart Home" untuk Seluruh Skenario Penggunaan di CES 2026
dan solusi TI pintar. Menurut Omdia, volume penjualan TV Hisense ukuran 100 inci dan lebih berada di peringkat No.1 dunia (periode 2023-Triwulan III-2025). Hisense merupakan pelopor RGB MiniLED yang terus menghadirkan inovasi generasi baru. Sebagai sponsor resmi FIFA Club World Cup 2026™, Hisense berkomitmen
More news about: Hisense
Jan 07, 2026, 17:31 ET Psoriasis Market to Exhibit Growth at a CAGR of 1.7% During the Forecast Period (2025-2034), Owing to Continuous Innovation in Biologic Therapies and Approval of Oral Small Molecules | DelveInsight
convenience without compromising efficacy.Promise of Takeda/Nimbus Therapeutics' ZasocitinibZasocitinib, a TYK2 inhibitor in Phase III trials, shows promise with its high efficacy and favorable safety profile compared to traditional JAK inhibitors. With up to one-third of patients achieving
More news about: DelveInsight Business Research, LLP
Jan 07, 2026, 16:43 ET Kuehn Law Encourages Investors of Dick's Sporting Goods, Inc. to Contact Law Firm
technology, and more efficient clearance channels, did not allow the Company to manage its excess inventory without hurting the Company's profitability; (iii) the need to liquidate excess inventory, including in the Outdoor segment, would have a materially negative effect on the Company's profitability; and
More news about: Kuehn Law, PLLC
Jan 07, 2026, 14:50 ET TreeHouse Foods Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TreeHouse Foods, Inc. - THS
TreeHouse Foods, Inc. (NYSE: THS) to Industrial F&B Investments III Inc. Under the terms of the proposed transaction, shareholders of TreeHouse will receive $22.50 in cash and one non-transferable Contingent Value Right
More news about: Kahn Swick & Foti, LLC
Jan 07, 2026, 14:10 ET OneStream schließt endgültige Vereinbarung zur Übernahme durch Hg für 6,4 Milliarden US-Dollar ab
zukunftsorientiert sind, können Aussagen zu folgenden Punkten enthalten: (i) der Transaktion; (ii) dem voraussichtlichen Zeitpunkt des Abschlusses der Transaktion; (iii) Erwägungen, die bei der Genehmigung und dem Abschluss der Transaktion berücksichtigt wurden; (iv) erwarteten Vorteilen oder Auswirkungen der Transaktion
More news about: OneStream, Inc.
Jan 07, 2026, 12:58 ET Harry Connick Jr. Returns Home to New Orleans to Welcome the Rockin'1000 Band of 1,000 Musicians from 25 Countries * Tickets on Sale Now
Rockin'1000 has gone on to fill stadiums across the planet, creating magical moments that transcend language, culture, and borders.Walt Leger III, President and CEO of New Orleans & Company, said, "We are honored to welcome back our native son, Harry Connick Jr., one of our most globally renowned
More news about: New Orleans & Company
Jan 07, 2026, 10:47 ET Na targach CES 2026 Hisense prezentuje kompleksowy ekosystem inteligentnego domu
rozwiązaniach IT. W rankingu firmy analitycznej Omdia firma Hisense zajmuje pozycję lidera w segmencie telewizorów 100-calowych i większych (lata 2023 - III kwartał 2025). Firma Hisense, będą twórcą technologii RGB MiniLED, wprowadza dalsze innowacje w zakresie telewizorów RGB MiniLED nowej generacji. Jako
More news about: Hisense
Jan 07, 2026, 10:32 ET How $594B in Precision Tech is Cracking the Metastatic Cancer Code
provided updates on its Phase III FLAMINGO-01 trial evaluating GLSI-100 to prevent breast cancer recurrences, announcing that preliminary analysis of the fully enrolled 250-patient non-HLA-A*02
More news about: USA News Group
Jan 07, 2026, 09:00 ET Warburg Pincus Closes on $3.0 Billion Financial Services Fund
Pincus, the pioneer of global growth investing, today announced it has successfully raised Warburg Pincus Financial Sector III, L.P. ("WPFS III"), closing on $3.0 billion of capital. WPFS III launched in 2024, with a target of $2.5 billion. Over the past five decades, Warburg Pincus has been a leader
More news about: Warburg Pincus LLC
Jan 07, 2026, 09:00 ET Thurston Group Portfolio Company, Alpha Aesthetics Partners, Secures $93 Million Financing to Drive Continued Growth
equity firm that focuses on building industry-leading companies in the healthcare services sector. Founded by its Chairman and CEO Patrick J. Haynes III in 1986, Thurston Group has returned more than $4 billion of invested capital in its 39-year history. Thurston has an extensive track record of partnering
More news about: Thurston Group
Jan 07, 2026, 08:45 ET Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds
the Company's common stock ("Common Stock") (or, in certain circumstances, pre-funded warrants to purchase Common Stock (the "Pre-Funded Warrants")), (iii) Series B warrants (the "Series B Warrants") to purchase 26,926,675 shares of Common Stock (or, in certain circumstances, Pre-Funded Warrants), and
More news about: Curis, Inc.